Prolactin inducible protein in cancer, fertility and immunoregulation: Structure, function and its clinical implications

Cellular and Molecular Life Sciences

Volumn 66, Issue 3, 2009, Pages 447-459

  Hassan, Md I ^a,c   Waheed, A ^b   Yadav, S ^c   Singh, T P ^c   Ahmad, F ^a  

^a JAMIA MILLIA ISLAMIA CENTRAL UNIVERSITY   (India)

^b SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Antisperm antibody; Apoptosis; CD4 T cell receptor; Fertilization; Prolactin inducible protein; Tumor progression and metastasis

Indexed keywords

ACTIN; ALPHA2 GLYCOPROTEIN; ANDROGEN; ASPARTIC PROTEINASE; BINDING PROTEIN; BIOLOGICAL MARKER; ESTROGEN; FIBRONECTIN; IMMUNOGLOBULIN FC FRAGMENT; IMMUNOGLOBULIN G; POLYPEPTIDE; PROLACTIN INDUCIBLE PROTEIN; SPERM ANTIBODY; T LYMPHOCYTE RECEPTOR; TUMOR MARKER; UNCLASSIFIED DRUG; ZINC;

AMINO ACID SEQUENCE; APOCRINE GLAND; BACTERIAL COLONIZATION; BACTERIAL GROWTH; BACTERIAL STRAIN; BIOLOGICAL ACTIVITY; BODY FLUID; BREAST CANCER; CD4+ T LYMPHOCYTE; CRYSTAL STRUCTURE; DENTAL PELLICLE; EXOCRINE GLAND; EXOCRINE SECRETION; FERTILITY; FERTILIZATION; GEMELLA; GENE CONTROL; GENE EXPRESSION; GENE STRUCTURE; GROWTH INHIBITION; HUMAN; IMMUNOREGULATION; LACRIMAL GLAND; LUNG; MAMMARY GLAND; MUSCLE; NEOPLASM; NUCLEOTIDE SEQUENCE; PROSTATE; PROSTATE CANCER; PROTEIN EXPRESSION; PROTEIN FOLDING; PROTEIN FUNCTION; PROTEIN STRUCTURE; PROTEOMICS; RECEPTOR UPREGULATION; REVIEW; SALIVARY GLAND; SEMINAL PLASMA; STAPHYLOCOCCUS HOMINIS; STREPTOCOCCUS; SWEAT GLAND; TRACHEA; TUMOR GROWTH;

AMINO ACID SEQUENCE; ANIMALS; CARRIER PROTEINS; DISEASE PROGRESSION; FERTILITY; GLYCOPROTEINS; HUMANS; IMMUNE SYSTEM PROCESSES; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; NEOPLASMS; PROLACTIN; PROTEIN CONFORMATION; SEQUENCE ALIGNMENT; TUMOR MARKERS, BIOLOGICAL;

EID: 59349120490     PISSN: 1420682X     EISSN: 15691632     Source Type: Journal    
DOI: 10.1007/s00018-008-8463-x     Document Type: Review

References (142)

1. Murphy, L.C., Tsuyuki, D., Myal, Y., and Shiu, R.P. (1987). Isolation and sequencing of a cDNA clone for a prolactin-inducible protein (PIP). Regulation of PIP gene expression in the human breast cancer cell line, T-47D. J. Biol. Chem. 262, 15236-15241.
2. Schenkels, L.C., Schaller, J., Walgreen-Weterings, E., Schadee-Eestermans, I.L., Veerman, E.C., and Nieuw Amerongen, A.V. (1994). Identity of human extra parotid glycoprotein (EP-GP) with secretory actin binding protein (SABP) and its biological properties. Biol. Chem. Hoppe Seyler 375, 609-615.
3. Shiu, R.P., and Iwasiow, B.M. (1985). Prolactin-inducible proteins in human breast cancer cells. J. Biol. Chem. 260, 11307-11313.
4. Haagensen, D.E., Jr., Mazoujian, G., Dilley, W.G., Pedersen, C.E., Kister, S.J., and Wells, S.A., Jr. (1979). Breast gross cystic disease fluid analysis. I. Isolation and radioimmunoassay for a major component protein. J. Natl. Cancer Inst. 62, 239-247.
5. Haagensen, D.E., Jr., Gall, S.A., Brazy, J.E., Giannola, J., and Wells, S.A., Jr. (1980). Analysis of amniotic fluid, maternal plasma, and cord blood for a human breast gross cystic disease fluid protein. Am. J. Obstet. Gynecol. 138, 25-32.
6. Autiero, M., Cammarota, G., Friedlein, A., Zulauf, M., Chiappetta, G., Dragone, V., and Guardiola, J. (1995). A 17-kDa CD4-binding glycoprotein present in human seminal plasma and in breast tumor cells. Eur. J. Immunol. 25, 1461-1464.
7. Rathman, W.M., Van Zeyl, M.J., Van den Keybus, P.A., Bank, R.A., Veerman, E.C., and Nieuw Amerongen, A.V. (1989). Isolation and characterization of three non-mucinous human salivary proteins with affinity for hydroxyapatite. J. Biol. Buccale 17, 199-208.
8. Myal, Y., Gregory, C., Wang, H., Hamerton, J.L., and Shiu, R.P. (1989). The gene for prolactin-inducible protein (PIP), uniquely expressed in exocrine organs, maps to chromosome 7. Somat. Cell Mol. Genet. 15, 265-270.
9. Myal, Y., Robinson, D.B., Iwasiow, B., Tsuyuki, D., Wong, P., and Shiu, R.P. (1991). The prolactin-inducible protein (PIP/GCDFP-15) gene: cloning, structure and regulation. Mol. Cell. Endocrinol. 80, 165-175.
10. Autiero, M., Gaubin, M., Mani, J.C., Castejon, C., Martin, M., el Marhomy, S., Guardiola, J., and Piatier-Tonneau, D. (1997). Surface plasmon resonance analysis of gp17, a natural CD4 ligand from human seminal plasma inhibiting human immunodeficiency virus type-1 gp120-mediated syncytium formation. Eur. J. Biochem. 245, 208-213.
11. Mazoujian, G., Pinkus, G.S., Davis, S., and Haagensen, D.E., Jr. (1983). Immunohistochemistry of a gross cystic disease fluid protein (GCDFP-15) of the breast. A marker of apocrine epithelium and breast carcinomas with apocrine features. Am. J. Pathol. 110, 105-112.
12. Cassoni, P., Sapino, A., Haagensen, D.E., Naldoni, C., and Bussolati, G. (1995). Mitogenic effect of the 15-kDa gross cystic disease fluid protein (GCDFP-15) on breast-cancer cell lines and on immortal mammary cells. Int. J. Cancer 60, 216-220.
13. Pagani, A., Sapino, A., Eusebi, V., Bergnolo, P., and Bussolati, G. (1994). PIP/GCDFP-15 gene expression and apocrine differentiation in carcinomas of the breast. Virchows Arch. 425, 459-465.
14. Schenkels, L.C., Walgreen-Weterings, E., Oomen, L.C., Bolscher, J.G., Veerman, E.C., and Nieuw Amerongen, A.V. (1997). In vivo binding of the salivary glycoprotein EP-GP (identical to GCDFP-15) to oral and non-oral bacteria detection and identification of EP-GP binding species. Biol. Chem. 378, 83-88.
15. Lopez-Otin, C., and Diamandis, E.P. (1998). Breast and prostate cancer: an analysis of common epidemiological, genetic, and biochemical features. Endocr. Rev. 19, 365-396.
16. Hahnel, R., and Hahnel, E. (1996). Expression of the PIP/GCDFP-15 gene and survival in breast cancer. Virchows Arch. 429, 365-369.
17. Simard, J., Hatton, A.C., Labrie, C., Dauvois, S., Zhao, H.F., Haagensen, D.E., and Labrie, F. (1989). Inhibitory effect of estrogens on GCDFP-15 mRNA levels and secretion in ZR-75-1 human breast cancer cells.Mol. Endocrinol. 3, 694-702.
18. Wick, M.R., Lillemoe, T.J., Copland, G.T., Swanson, P.E., Manivel, J.C., and Kiang, D.T. (1989). Gross cystic disease fluid protein-15 as a marker for breast cancer: immunohistochemical analysis of 690 human neoplasms and comparison with alpha-lactalbumin. Hum. Pathol. 20, 281-287.
19. Haagensen, D.E. (1981). Biochemical relationship between gross cystic disease and breast carcinoma. In Haagensen CD, Bodian C, Haagensen DE Jr, eds. Breast Carcinoma: Risk and Detection. Philadelphia, WB Saunders,, 300-338.
20. Estabrook, A., Kister, S.J., Hardy, M.A., Grossbard, L., Oster, M.W., Davis, S., Mazoujian, G., and Haagensen, D.E., Jr. (1986). Non-human primate (baboon) anti-gross cystic disease fluid protein-15 antibody infusion in four women with metastatic breast carcinoma. Cancer Immunol. Immunother. 23, 143-147.
21. Mazoujian, G., Bodian, C., Haagensen, D.E., Jr., and Haagensen, C.D. (1989). Expression of GCDFP-15 in breast carcinomas. Relationship to pathologic and clinical factors. Cancer 63, 2156-2161.
22. Swanson, P.E., Pettinato, G., Lillemoe, T.J., and Wick, M.R. (1991). Gross cystic disease fluid protein-15 in salivary gland tumors. Arch. Pathol. Lab. Med. 115, 158-163.
23. Ansai, S., Koseki, S., Hozumi, Y., and Kondo, S. (1995). An immunohistochemical study of lysozyme, CD-15 (Leu M1), and gross cystic disease fluid protein-15 in various skin tumors. Assessment of the specificity and sensitivity of markers of apocrine differentiation. Am. J. Dermatopathol. 17, 249-255.
24. Mirels, L., Hand, A.R., and Branin, H.J. (1998). Expression of gross cystic disease fluid protein-15/Prolactin-inducible protein in rat salivary glands. J. Histochem. Cytochem. 46, 1061-1071.
25. Martinez-Heredia, J., de Mateo, S., Vidal-Taboada, J.M., Ballesca, J.L., and Oliva, R. (2008). Identification of proteomic differences in asthenozoospermic sperm samples. Hum. Reprod. 23, 783-791.
26. Hassan, M.I., Kumar, V., Kashav, T., Alam, N., Singh, T.P., and Yadav, S. (2007). Proteomic approach for purification of seminal plasma proteins involved in tumor proliferation. J. Sep. Sci. 30, 1979-1988.
27. Schaller, J., Akiyama, K., Kimura, H., Hess, D., Affolter, M., and Rickli, E.E. (1991). Primary structure of a new actin-binding protein from human seminal plasma. Eur. J. Biochem. 196, 743-750.
28. Gaubin, M., Autiero, M., Basmaciogullari, S., Metivier, D., Mis hal, Z., Culerrier, R., Oudin, A., Guardiola, J., and Piatier-Tonneau, D. (1999). Potent inhibition of CD4/TCR-mediated T cell apoptosis by a CD4-binding glycoprotein secreted from breast tumor and seminal vesicle cells. J. Immunol. 162, 2631-2638.
29. Chiu, W.W., and Chamley, L.W. (2003). Human seminal plasma prolactin-inducible protein is an immunoglobulin G-binding protein. J. Reprod. Immunol. 60, 97-111.
30. Chiu, W.W., and Chamley, L.W. (2003). Human seminal plasma antibody-binding proteins. Am. J. Reprod. Immunol. 50, 196-201.
31. Osawa, M., Seto, Y., Yukawa, N., Saito, T., and Takeichi, S. (1996). A 20-kDa protein in human seminal plasma that is identical to gross cystic disease fluid protein 15 and prolactin-inducible protein. Arch. Androl. 36, 29-39.
32. Caputo, E., Carratore, V., Ciullo, M., Tiberio, C., Mani, J.C., Piatier-Tonneau, D., and Guardiola, J. (1999). Biosynthesis and immunobiochemical characterization of gp17/GCDFP-15. A glycoprotein from seminal vesicles and from breast tumors, in HeLa cells and in Pichia pastoris yeast. Eur. J. Biochem. 265, 664-670.
33. Vandewalle, B., Hornez, L., Vennin, P., Peyrat, J.P., and Lefebvre, J. (1986). Further characterization of the light breast cyst fluid protein, GCDFP-15. Biochimie 68, 649-656.
34. Pasquinelli, R., Barba, P., Capasso, I., D'Aiuto, M., D'Aiuto, G., Anzisi, A.M., De Berardinis, P., and Guardiola, J. (1999). Circulating antibodies against the breast tumor marker GCDFP-15/gp17 in mammary carcinoma patients and in patients carrying benign breast conditions. Int. J. Cancer 84, 568-572.
35. Zagorianakou, P., Zagorianakou, N., Stefanou, D., Makrydimas, G., and Agnantis, N.J. (2006). The enigmatic nature of apocrine breast lesions. Virchows Arch. 448, 525-531.
36. Nakamura, G., Shikata, N., Shoji, T., Hatano, T., Hioki, K., and Tsubura, A. (1995). Immunohistochemical study of mammary and extramammary Paget's disease. Anticancer Res. 15, 467-470.
37. Sapino, A., Cassoni, P., and Bussolati, G. (2000). Gross cystic disease fluid protein (GCDFP-15) in the breast: past and present. J. Biol. Regul. Homeost. Agents 14, 259-262.
38. Schmitt, F.C., Soares, R., and Seruca, R. (1998). Bilateral apocrine carcinoma of the breast. Molecular and immunocytochemical evidence for two independent primary tumours. Virchows Arch.433, 505-509.
39. Shiu, R.P., Murphy, L.C., Tsuyuki, D., Myal, Y., Lee-Wing, M., and Iwasiow, B. (1987). Biological actions of prolactin in human breast cancer. Recent Prog. Horm. Res. 43, 277-303.
40. Osawa, M., Horiuchi, H., Tian, W., and Kaneko, M. (2004). Divergent evolution of the prolactin-inducible protein gene and related genes in the mouse genome. Gene 325, 179-186.
41. Sheiness, D., and Darnell, J.E. (1973). Polyadenylic acid segment in mRNA becomes shorter with age. Nat. New Biol. 241, 265-268.
42. Carsol, J.L., Gingras, S., and Simard, J. (2002). Synergistic action of prolactin (PRL) and androgen on PRL-inducible protein gene expression in human breast cancer cells: a unique model for functional cooperation between signal transducer and activator of transcription-5 and androgen receptor. Mol. Endocrinol. 16, 1696-1710.
43. Myal, Y., Iwasiow, B., Cosby, H., Yarmill, A., Blanchard, A., Tsuyuki, D., Fresnoza, A., Duckworth, M.L., and Shiu, R.P. (1998). Analysis of tissue- and hormone-specific regulation of the human prolactin-inducible protein/gross cystic disease fluid protein-15 gene in transgenic mice. J. Mol. Endocrinol. 21, 217-223.
44. Shiu, R.P., Murphy, L.C., Myal, Y., Dembinski, T.C., Tsuyuki, D., and Iwasiow, B.M. (1988). Actions of pituitary prolactin and insulin-like growth factor II in human breast cancer. Cancer Treat. Res. 40, 167-183.
45. Blais, Y., Sugimoto, K., Carriere, M.C., Haagensen, D.E., Labrie, F., and Simard, J. (1994). Potent stimulatory effect of interleukin-1 alpha on apolipoprotein D and gross cystic disease fluid protein-15 expression in human breast-cancer cells. Int. J. Cancer 59, 400-407.
46. Blais, Y., Sugimoto, K., Carriere, M.C., Haagensen, D.E., Labrie, F., and Simard, J. (1995). Interleukin-6 inhibits the potent stimulatory action of androgens, glucocorticoids and interleukin-1 alpha on apolipoprotein D and GCDFP-15 expression in human breast cancer cells. Int. J. Cancer 62, 732-737.
47. Lee, B., Modha, G., Watson, P.H., Dodd, J., Troup, S., Blanchard, A., and Myal, Y. (2003). Expression of the mouse homologue for the human GCDFP-15/PIP gene during pre- and early post-natal development. Mol. Cell. Endocrinol. 205, 33-41.
48. Loos, S., Schulz, K.D., and Hackenberg, R. (1999). Regulation of GCDFP-15 expression in human mammary cancer cells. Int. J. Mol. Med. 4, 135-140.
49. Myal, Y., Iwasiow, B., Yarmill, A., Harrison, E., Paterson, J.A., and Shiu, R.P. (1994).Tissue-specific androgen-inhibited gene expression of a submaxillary gland protein, a rodent homolog of the human prolactin-inducible protein/GCDFP-15 gene. Endocrinology 135, 1605-1610.
50. Dilley, W.G., Leight, G.S., Jr., Silva, J.S., Ammirata, S., Haagensen, D.E., and Wells, S.A., Jr. (1983). Androgen stimulation of gross cystic disease fluid protein and carcinoembryonic antigen in patients with metastatic breast carcinoma. J. Natl. Cancer Inst. 70, 69-74.
51. Hall, R.E., Clements, J.A., Birrell, S.N., and Tilley, W.D. (1998). Prostate-specific antigen and gross cystic disease fluid protein-15 are co-expressed in androgen receptor-positive breast tumours. Br. J. Cancer 78, 360-365.
52. Haagensen, D.E., Stewart, P., Dilley, W.G., and Wells, S.A. (1992). Secretion of breast gross cystic disease fluid proteins by T47D breast cancer cells in culture-modulation by steroid hormones. Breast Cancer Res. Treat. 23, 77-86.
53. Myal, Y., Iwasiow, B., Yarmill, A., and Shiu, R.P. (1996). A new member of the hormonally regulated rodent submaxillary gland glycoprotein gene family: cDNA cloning and tissue specific expression. Mol. Cell. Endocrinol. 120, 133-138.
54. Dauvois, S., Simard, J., Dumont, M., Haagensen, D.E., and Labrie, F. (1990). Opposite effects of estrogen and the progestin R5020 on cell proliferation and GCDFP-15 expression in ZR-75-1 human breast cancer cells. Mol. Cell. Endocrinol. 73, 171-178.
55. Labrie, F., Simard, J., Poulin, R., Hatton, A.C., Labrie, C., Dauvois, S., Zhao, H.F., Petitclerc, L., Couet, J., Dumont, M., and et al. (1990). Potent antagonism between estrogens and androgens on GCDFP-15 expression and cell growth in the ZR-75-1 human breast cancer cells. Ann. N. Y. Acad. Sci. 586, 174-187.
56. Hassan, M.I., Kumar, V., Singh, T.P., and Yadav, S. (2008). Purification and characterization of zinc alpha2-glycoprotein-Prolactin inducible protein complex from human seminal plasma. J. Sep. Sci. 31, 2318-2324.
57. Akiyama, K., and Kimura, H. (1990). Isolation of a new actin-binding protein from human seminal plasma. Biochim. Biophys. Acta 1040, 206-210.
58. Caputo, E., Camarca, A., Moharram, R., Tornatore, P., Thatcher, B., Guardiola, J., and Martin, B.M. (2003). Structural study of GCDFP-15/gp17 in disease versus physiological conditions using a proteomic approach. Biochemistry 42, 6169-6178.
59. Garnier, J., Osguthorpe, D.J., and Robson, B. (1978). Analysis of the accuracy and implications of simple methods for predicting the secondary structure of globular proteins. J. Mol. Biol. 120, 97-120.
60. Klein, P., Kanehisa, M., and DeLisi, C. (1985). The detection and classification of membrane-spanning proteins. Biochim. Biophys. Acta 815, 468-476.
61. Kitano, T., Tian, W., Umetsu, K., Yuasa, I., Yamazaki, K., Saitou, N., and Osawa, M. (2006). Origin and evolution of gene for prolactin-induced protein. Gene 383, 64-70.
62. Windass, J.D., Mullins, J.J., Beecroft, L.J., George, H., Meacock, P.A., Williams, B.R., and Brammar, W.J. (1984). Molecular cloning of cDNAs from androgen-independent mRNA species of DBA/2 mouse sub-maxillary glands. Nucleic Acids Res. 12, 1361-1376.
63. Tellam, R.L., Morton, D.J., and Clarke, F.M. (1989). A common theme in the amino acid sequences of actin and many actin-binding proteins? Trends Biochem. Sci. 14, 130-133.
64. Caputo, E., Manco, G., Mandrich, L., and Guardiola, J. (2000). A novel aspartyl proteinase from apocrine epithelia and breast tumors. J. Biol. Chem. 275, 7935-7941.
65. Miller, M., Jaskolski, M., Rao, J.K., Leis, J., and Wlodawer, A. (1989). Crystal structure of a retroviral protease proves relationship to aspartic protease family. Nature 337, 576-579.
66. Lilja, H., Abrahamsson, P.A., and Lundwall, A. (1989). Semenogelin, the predominant protein in human semen. Primary structure and identification of closely related proteins in the male accessory sex glands and on the spermatozoa. J. Biol. Chem. 264, 1894-1900.
67. Autiero, M., Abrescia, P., and Guardiola, J. (1991). Interaction of seminal plasma proteins with cell surface antigens: presence of a CD4-binding glycoprotein in human seminal plasma. Exp. Cell Res. 197, 268-271.
68. Leahy, D.J., Aukhil, I., and Erickson, H.P. (1996). 2.0 A crystal structure of a four-domain segment of human fibronectin encompassing the RGD loop and synergy region. Cell 84, 155-164.
69. Mazoujian, G., and Margolis, R. (1988). Immunohistochemistry of gross cystic disease fluid protein (GCDFP-15) in 65 benign sweat gland tumors of the skin. Am. J. Dermatopathol. 10, 28-35.
70. Hassan, M.I., Bilgrami, S., Kumar, V., Singh, N., Yadav, S., Kaur, P., and Singh, T.P. (2008). Crystal structure of a novel complex of zinc alpha2-glycoprotein-Prolactin inducible protein complex from human seminal plasma. J. Mol. Biol. (in press).
71. Schenkels, L.C., Veerman, E.C., and Nieuw Amerongen, A.V. (1995). EP-GP and the lipocalin VEGh, two different human salivary 20-kDa proteins. J. Dent. Res. 74, 1543-1550.
72. Witkin, S.S., Richards, J.M., Bongiovanni, A.M., and Zelikovsky, G. (1983). An IgG-Fc binding protein in seminal fluid. Am J. Reprod. Immunol. 3, 23-27.
73. Bronson, R.A. (1999). Antisperm antibodies: a critical evaluation and clinical guidelines. J. Reprod. Immunol. 45, 159-183.
74. Bergamo, P., Balestrieri, M., Cammarota, G., Guardiola, J., and Abrescia, P. (1997). CD4-mediated anchoring of the seminal antigen gp17 onto the spermatozoon surface. Hum. Immunol. 58, 30-41.
75. Kelly, R.W. (1995). Immunosuppressive mechanisms in semen: implications for contraception. Hum Reprod 10, 1686-1693.
76. Thaler, C.J., Faulk, W.P., and McIntyre, J.A. (1989). Soluble antigens of IgG receptor Fc gamma RIII in human seminal plasma. J. Immunol. 143, 1937-1942.
77. Liang, Z.G., Kamada, M., and Koide, S.S. (1991). Structural identity of immunoglobulin binding factor and prostatic secretory protein of human seminal plasma. Biochem. Biophys. Res. Commun. 180, 356-359.
78. Caputo, E., Autiero, M., Mani, J.C., Basmociogullari, S., Piatier-Tonneau, D., and Guardiola, J. (1998). Differential antibody reactivity and CD4 binding of the mammary tumor marker protein GCDFP-15 from breast cyst and its counter-parts from exocrine epithelia. Int. J. Cancer 78, 76-85.
79. Janeway, C.A., Jr. (1989).The role of CD4in T-cell activation: accessory molecule or co-receptor? Immunol. Today 10, 234-238.
80. Haagensen, D.E., Jr., and Mazoujian, G. (1986). in Diseases of the Breast. (Haagensen, C. D., Ed.). pp 474-500, W. B. Saunders Co., Philadelphia.
81. Chaubert, P., and Hurlimann, J. (1992). Mammary origin of metastases. Immunohistochemical determination. Arch. Pathol. Lab. Med. 116, 1181-1188.
82. Oyaizu, N., Chirmule, N., Kalyanaraman, V.S., Hall, W.W., Pahwa, R., Shuster, M., and Pahwa, S. (1990). Human immunodeficiency virus type 1 envelope glycoprotein gp120 produces immune defects in CD4+ T lymphocytes by inhibiting interleukin 2 mRNA. Proc. Natl. Acad. Sci. U. S. A. 87, 2379-2383.
83. Finkel, T.H., Tudor-Williams, G., Banda, N.K., Cotton, M.F., Curiel, T., Monks, C., Baba, T.W., Ruprecht, R.M., and Kupfer, A. (1995). Apoptosis occurs predominantly in by-stander cells and not in productively infected cells of HIV- and SIV-infected lymph nodes. Nat. Med. 1, 129-134.
84. Garzino-Demo, A., DeVico, A.L., and Gallo, R.C. (1998). Chemokine receptors and chemokines in HIV infection. J. Clin. Immunol. 18, 243-255.
85. Millea, K.M., Krull, I.S., Chakraborty, A.B., Gebler, J.C., and Berger, S.J. (2007). Comparative profiling of human saliva by intact protein LC/ESI-TOF mass spectrometry. Biochim. Biophys. Acta 1774, 897-906.
86. Neyraud, E., Sayd, T., Morzel, M., and Dransfield, E. (2006). Proteomic analysis of human whole and parotid salivas following stimulation by different tastes. J. Proteome Res. 5, 2474-2480.
87. Yang, L.L., Liu, X.Q., Liu, W., Cheng, B., and Li, M.T. (2006). Comparative analysis of whole saliva proteomes for the screening of biomarkers for oral lichen planus. Inflamm. Res. 55, 405-407.
88. Huang, C.M. (2004). Comparative proteomic analysis of human whole saliva. Arch. Oral Biol. 49, 951-962.
89. Siqueira, W.L., Zhang, W., Helmerhorst, E.J., Gygi, S.P., and Oppenheim, F.G. (2007). Identification of protein components in in vivo human acquired enamel pellicle using LC-ESI-MS/MS. J. Proteome Res. 6, 2152-2160.
90. Rathman, W.M., van Zeyl, M.J., van den Keijbus, P.A., Veerman, E.C., and Nieuw Amerongen, A.V. (1990). Comparison of a salivary 14 kD protein displaying cysteine proteinase inhibitory activity with other salivary cystatins. J. Biol. Buccale 18, 9-18.
91. Rathman, W.M., van den Keybus, P.A., van Zeyl, M.J., Dopp, E.A., Veerman, E.C., and Nieuw Amerongen, A.V. (1990). Characterization of monoclonal antibodies to human salivary (glyco) proteins. Cellular localization of mucin, cystatin-like 14 kD protein and 20 kD glycoprotein in the human submandibular gland. J. Biol. Buccale 18, 19-27.
92. Takeda, Y., Tsuta, K., Shibuki, Y., Hoshino, T., Tochigi, N., Maeshima, A.M., Asamura, H., Sasajima, Y., Ito, T., and Matsuno, Y. (2008). Analysis of expression patterns of breast cancer-specific markers (mammaglobin and gross cystic disease fluid protein 15) in lung and pleural tumors. Arch. Pathol. Lab. Med. 132, 239-243.
93. Fritzsche, F.R., Thomas, A., Winzer, K.J., Beyer, B., Dankof, A., Bellach, J., Dahl, E., Dietel, M., and Kristiansen, G. (2007). Co-expression and prognostic value of gross cystic disease fluid protein 15 and mammaglobin in primary breast cancer. Histol. Histopathol. 22, 1221-1230.
94. Nonami, Y., Hisa, S., Yamamoto, A., Sasaguri, S., Kiyoku, H., and Kurumaya, H. (2001). Immunohistochemical study with antibody to glycoprotein GCDFP-15 for metastatic lung cancer from breast cancer. J. Cardiovasc. Surg. (Torino) 42, 561-564.
95. Miller, W.R., Shivas, A.A., Franchimont, P., and Haagensen, D.E. (1988). Breast gross cystic disease protein 15 in human breast cancer in culture. Eur. J. Cancer Clin. Oncol. 24, 223-228.
96. Dumont, M., Dauvois, S., Simard, J., Garcia, T., Schachter, B., and Labrie, F. (1989). Antagonism between estrogens and androgens on GCDFP-15 gene expression in ZR-75-1 cells and correlation between GCDFP-15 and estrogen as well as progesterone receptor expression in human breast cancer. J. Steroid Biochem. 34, 397-402.
97. Bundred, N.J., Stewart, H.J., Shaw, D.A., Forrest, A.P., and Miller, W.R. (1990). Relation between apocrine differentiation and receptor status, prognosis and hormonal response in breast cancer. Eur. J. Cancer 26, 1145-1147.
98. Myal, Y., Blanchard, A., Watson, P., Corrin, M., Shiu, R., and Iwasiow, B. (2000). Detection of genetic point mutations by peptide nucleic acid-mediated polymerase chain reaction clamping using paraffin-embedded specimens. Anal. Biochem. 285, 169-172.
99. Murphy, L.C., Lee-Wing, M., Goldenberg, G.J., and Shiu, R.P. (1987). Expression of the gene encoding a prolactin-inducible protein by human breast cancers in vivo: correlation with steroid receptor status. Cancer Res. 47, 4160-4164.
100. Sanchez, L.M., Vizoso, F., Diez-Itza, I., and Lopez-Otin, C. (1992). Identification of the major protein components in breast secretions from women with benign and malignant breast diseases. Cancer Res. 52, 95-100.
101. Chalbos, D., Haagensen, D., Parish, T., and Rochefort, H. (1987). Identification and androgen regulation of two proteins released by T47D human breast cancer cells. Cancer Res. 47, 2787-2792.
102. Simard, J., Dauvois, S., Haagensen, D.E., Levesque, C., Merand, Y., and Labrie, F. (1990). Regulation of progesterone-binding breast cyst protein GCDFP-24 secretion by estrogens and androgens in human breast cancer cells: a new marker of steroid action in breast cancer. Endocrinology 126, 3223-3231.
103. Dennis, J.L., Hvidsten, T.R., Wit, E.C., Komorowski, J., Bell, A.K., Downie, I., Mooney, J., Verbeke, C., Bellamy, C., Keith, W.N., and Oien, K.A. (2005). Markers of adenocarcinoma characteristic of the site of origin: development of a diagnostic algorithm. Clin Cancer Res. 11, 3766-3772.
104. Brown, R.W., Campagna, L.B., Dunn, J.K., and Cagle, P.T. (1997). Immunohistochemical identification of tumor markers in metastatic adenocarcinoma. A diagnostic adjunct in the determination of primary site. Am. J. Clin. Pathol. 107, 12-19.
105. Autiero, M., Culerrier, R., Bouchier, C., Basmaciogullari, S., Gaubin, M., ElMarhomy, S., Blanchet, P., Paradis, V., Jardin, A., Guardiola, J., and Piatier-Tonneau, D. (1999). Abnormal restriction pattern of PIP gene associated with human primary prostate cancers. DNA Cell Biol. 18, 481-487.
106. Tian, W., Osawa, M., Horiuchi, H., and Tomita, Y. (2004). Expression of the prolactin-inducible protein (PIP/GCDFP15) gene in benign epithelium and adenocarcinoma of the prostate. Cancer Sci. 95, 491-495.
107. Lagendijk, J.H., Mullink, H., van Diest, P.J., Meijer, G.A., and Meijer, C.J. (1999). Immunohistochemical differentiation between primary adenocarcinomas of the ovary and ovarian metastases of colonic and breast origin. Comparison between a statistical and an intuitive approach. J. Clin. Pathol. 52, 283-290.
108. Harada, M., Fukuta, Y., Horiuchi, M., Ikawa, K., Matsumura, T., Terashima, Y., Hino, A., Uehara, H., Maeda, T., and Tashiro, S. (2001). Simultaneous resection of pancreas and liver metastases from different metachronous primary cancers. J. Hepatobiliary Pancreat. Surg. 8, 479-484.
109. Perry, A., Parisi, J.E., and Kurtin, P.J. (1997). Metastatic adenocarcinoma to the brain: an immunohistochemical approach. Hum. Pathol. 28, 938-943.
110. Kracht, J., Sapino, A., and Bussolati, G. (1998). Malignant phyllodes tumor of breast with lung metastases mimicking the primary. Am. J. Surg. Pathol. 22, 1284-1290.
111. Castro, C.Y., Moran, C.A., Flieder, D.G., and Suster, S. (2001). Primary signet ring cell adenocarcinomas of the lung: a clinicopathological study of 15 cases. Histopathology 39, 397-401.
112. Striebel, J.M., Dacic, S., and Yousem, S.A. (2008). Gross cystic disease fluid protein-(GCDFP-15): expression in primary lung adenocarcinoma. Am. J. Surg. Pathol. 32, 426-432.
113. Ruoslahti, E., Simons, K., and Ehnholm, C. (1971). Immunological purification and chemical characterization of the group-specific proteins (Gc) from human serum. Eur. J. Immunol. 1, 45-48.
114. Yamada, K.M. (1983). Cell surface interactions with extracellular materials. Annu Rev Biochem 52, 761-799.
115. Jones, P.A., and DeClerck, Y.A. (1980). Destruction of extracellular matrices containing glycoproteins, elastin, and collagen by metastatic human tumor cells. Cancer Res. 40, 3222-3227.
116. Hauzenberger, D., Bergstrom, S.E., Klominek, J., and Sundqvist, K.G. (1999). Spectrum of extracellular matrix degrading enzymes in normal and malignant T lymphocytes. Anticancer Res. 19, 1945-1952.
117. Pellat, B., Planchenault, T., Keil-Dlouha, V., and Pellerin, C. (1988). Fibronectin-degrading activity in human crevicular fluid, gingival explants culture medium and bacterial plaques. J. Biol. Buccale 16, 51-57.
118. Larjava, H., Uitto, V.J., Haapasalo, M., Heino, J., and Vuento, M. (1987). Fibronectin fragmentation induced by dental plaque and Bacteroides gingivalis. Scand J. Dent. Res. 95, 308-314.
119. Laidler, P., and Litynska, A. (1997). Tumor cell N-glycans in metastasis. Acta Biochim. Pol. 44, 343-357.
120. Basmaciogullari, S., Autiero, M., Culerrier, R., Mani, J.C., Gaubin, M., Mishal, Z., Guardiola, J., Granier, C., and Piatier-Tonneau, D. (2000). Mapping the CD4 binding domain of gp17, a glycoprotein secreted from seminal vesicles and breast carcinomas. Biochemistry 39, 5332-5340.
121. Klas, C., Debatin, K.M., Jonker, R.R., and Krammer, P.H. (1993). Activation interferes with the APO-1 pathway in mature human T cells. Int. Immunol. 5, 625-630.
122. Ju, S.T., Panka, D.J., Cui, H., Ettinger, R., el-Khatib, M., Sherr, D.H., Stanger, B.Z., and Marshak-Rothstein, A. (1995). Fas(CD95)/FasL interactions required for programmed cell death after T-cell activation. Nature 373, 444-448.
123. Nagata, S., and Golstein, P. (1995). The Fas death factor. Science 267, 1449-1456.
124. Sanchez, L.M., Chirino, A.J., and Bjorkman, P. (1999). Crystal structure of human ZAG, a fat-depleting factor related to MHC molecules. Science 283, 1914-1919.
125. Huber, A.H., Wang, Y.M., Bieber, A.J., and Bjorkman, P.J. (1994). Crystal structure of tandem type III fibronectin domains from Drosophila neuroglian at 2.0 A. Neuron 12, 717-731.
126. Sauer, F.G., Futterer, K., Pinkner, J.S., Dodson, K.W., Hultgren, S.J., and Waksman, G. (1999). Structural basis of chaperone function and pilus biogenesis. Science 285, 1058-1061.
127. Yoshida, A., Kodama, Y., Hatanaka, S., Takasaki, T., Kuriwaki, K., and Yoshida, H. (1991). Apocrine adenocarcinoma of the bilateral axillae. Acta Pathol. Jpn. 41, 927-932.
128. Langel, D.J., Yeatts, R.P., and White, W.L. (2001). Primary signet ring cell carcinoma of the eyelid: report of a case demonstrating further analogy to lobular carcinoma of the breast with a literature review. Am. J. Dermatopathol. 23, 444-449.
129. Li, N., Wolgamot, G., and Argenyi, Z. (2007). Primary cutaneous neuroendocrine cell carcinoma (Merkel cell carcinoma) with prominent microcystic features, mimicking eccrine carcinoma. J. Cutan. Pathol. 34, 410-414.
130. Willman, J.H., Golitz, L.E., and Fitzpatrick, J.E. (2003). Clear cells of Toker in accessory nipples. J. Cutan. Pathol. 30, 256-260.
131. Marucci, G., Betts, C.M., Golouh, R., Peterse, J.L., Foschini, M.P., and Eusebi, V. (2002). Toker cells are probably precursors of Paget cell carcinoma: a morphological and ultrastructural description. Virchows Arch. 441, 117-123.
132. Rieske, P., and Pongubala, J.M. (2001). AKT induces transcriptional activity of PU.1 through phosphorylation-mediated modifications within its transactivation domain. J. Biol. Chem. 276, 8460-8468.
133. Higo, R., Takahashi, T., Nakata, H., Harada, H., and Sugasawa, M. (2007). Salivary duct carcinoma in the sinonasal tract. Eur. Arch. Otorhinolaryngol. 264, 561-563.
134. Lewis, J.E., McKinney, B.C., Weiland, L.H., Ferreiro, J.A., and Olsen, K.D. (1996). Salivary duct carcinoma. Clinicopathologic and immunohistochemical review of 26 cases. Cancer 77, 223-230.
135. Sapino, A., Frigerio, A., Peterse, J.L., Arisio, R., Coluccia, C., and Bussolati, G. (2000). Mammographically detected in situ lobular carcinomas of the breast. Virchows Arch. 436, 421-430.
136. Hisaoka, M., Takamatsu, Y., Hirano, Y., Maeda, H., and Hamada, T. (2006). Sebaceous carcinoma of the breast: case report and review of the literature. Virchows Arch. 449, 484-488.
137. Brown, H.M., and Wilkinson, E.J. (2002). Uroplakin-III to distinguish primary vulvar Paget disease from Paget disease secondary to urothelial carcinoma. Hum. Pathol. 33, 545-548.
138. Snijders, P.J., Meijer, C.J., and Walboomers, J.M. (1991). Degenerate primers based on highly conserved regions of amino acid sequence in papillomaviruses can be used in a generalized polymerase chain reaction to detect productive human papillomavirus infection. J. Gen. Virol. 72 ( Pt 11), 2781-2786.
139. Hungermann, D., Roeser, K., Buerger, H., Jakel, T., Loning, T., and Herbst, H. (2005). [Salivary duct carcinoma]. Pathologe 26, 353-358.
140. Heller, D.S., Haefner, H.K., Hameed, M., and Lieberman, R.W. (2002). Vulvar hidradenitis suppurativa. Immunohistochemical evaluation of apocrine and eccrine involvement. J. Reprod. Med. 47, 695-700.
141. von Mering, C., Jensen, L.J., Kuhn, M., Chaffron, S., Doerks, T., Kruger, B., Snel, B., and Bork, P. (2007). STRING 7-recent developments in the integration and prediction of protein interactions. Nucleic Acids Res. 35, D358-362.
142. von Mering, C., Jensen, L.J., Snel, B., Hooper, S.D., Krupp, M., Foglierini, M., Jouffre, N., Huynen, M.A., and Bork, P. (2005). STRING: known and predicted protein-protein associations, integrated and transferred across organisms. Nucleic Acids Res. 33, D433-437.